Journal profile · Medicine-Urology
Translational Andrology and Urology
ISSN 2223-4683 · eISSN 2223-4691 · AME Publishing Company · China
Translational Andrology and Urology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.88; fully open access; median 67 days to acceptance (100 articles, last 24 months); 372 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Translational Andrology and Urology is published by AME Publishing Company and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bladder and Urothelial Cancer Treatments, Prostate Cancer Diagnosis and Treatment and Sexual function and dysfunction studies, together about 26.3% of its articles. Its main subfields are Surgery and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Translational Andrology and Urology (TAU; Transl Androl Urol; Print ISSN 2223-4683; Online ISSN 2223-4691; http://tau.amegroups.com) is an open access, peer-reviewed and monthly journal that covers various aspects in diseases of male and female urinary tract including kidneys, ureters, bladder and urethra and the male reproductive organs like penis, testes, scrotum, prostate, etc. TAU is indexed in PubMed/PubMed Central (PMC), Scopus and Web of Science [Science Citation Index Expanded (SCIE)] and its latest impact factor for TAU is 1.9. Meanwhile, TAU is endorsed by the Genitourinary Medical Association of China International Exchange and Promotive Association for Medical and Health Care (GUA-CPAM).
From the journal's Aims & Scope
Research area (LetPub): Medicine-Urology
Editorial board by country: 4 in mainland China (about 7%); most named United States 31, Mainland China 4, Japan 3, Germany 3, Australia 3 (55 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bladder and Urothelial Cancer TreatmentsMedicine10.4%
- Prostate Cancer Diagnosis and TreatmentMedicine8.2%
- Sexual function and dysfunction studiesMedicine7.8%
- Urinary Bladder and Prostate ResearchMedicine6.5%
- Prostate Cancer Treatment and ResearchMedicine5.8%
- Urological Disorders and TreatmentsMedicine5.8%
- Urinary and Genital Oncology StudiesMedicine5.5%
- Sperm and Testicular FunctionMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Andrology | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Andrology | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Andrology | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.88LetPub ·
- Impact factor (publisher)
- 1.9Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- CiteScore (publisher) 2025
- 2.4Publisher website ·
- SJR 2026-06
- 0.51LetPub ·
- SNIP 2026-06
- 0.66LetPub ·
- h-index
- 64OpenAlex ·
- i10-index
- 966OpenAlex ·
- 2-year mean citedness
- 1.79OpenAlex ·
- Self-citation rate
- 5.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 321LetPub ·
Articles by year OpenAlex count · 3,949 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 352 | 352 | 335 |
| 2025 | 372 | 372 | 502 |
| 2024 | 295 | 295 | 988 |
| 2023 | 194 | 194 | 1,181 |
| 2022 | 190 | 190 | 1,441 |
| 2021 | 439 | 439 | 5,237 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
67 daysMedian, submission to acceptance · P25–P75 50 days – 84 days
- Acceptance to online
- median 26 days (100 articles)
- Submission to online
- median 94 days
- Sample
- 100 articles with submission and acceptance dates (751 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Peer review
- Open peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- 200–450 words
- Keywords
- 3–5
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Highlights
- Required
Article types accepted22
- brief reportBrief ReportLength not stated
- case reportManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- case report: imdt cornerCase Report: iMDT CornerLength not stated
- case seriesCase SeriesLength not stated
- clinical practice guidelineClinical Practice GuidelineLength not stated
- clinical practice reviewClinical Practice ReviewLength not stated
- editorialEditorialLength not stated
- editorial commentaryEditorial CommentaryLength not stated
- expert consensusExpert ConsensusLength not stated
- images in clinical medicineImages in Clinical MedicineLength not stated
- letter to the editorLetter to the EditorLength not stated
- literature reviewManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- mini-reviewMini-ReviewLength not stated
- narrative/literature reviewNarrative/Literature ReviewLength not stated
- original articleManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- othersOthersLength not stated
- reviewManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- review articleManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
- scoping reviewScoping ReviewLength not stated
- study protocolStudy ProtocolLength not stated
- surgical techniqueSurgical TechniqueLength not stated
- systematic reviewManuscript categories Word limit Abstract Key words Main text Reference Tables and Figures Structure template Original Article No limit Structured with Backgrou…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Publication ethics, License & copyright, Open access
- AI use Filling the Information Gap: A Validated Comparison of ChatGPT, Gemini and Claude for Penile Cancer Patient Education
Jeffery Yang, Ymer Bushati, Sarah Lorger, Jeremy Saad, Prem Rathore Published online: 11 August 2026
Source ↗Publisher website ·- Authorship 3.2 Authorship and Author contributions
3.2.1 AuthorshipAuthors should meet all four of the ICMJE’s authorship criteria listed below for authorship (1):
Source ↗Publisher website ·- Publication ethics
Adheres to ICMJE Recommendations, COPE Code of Conduct, and WAME policy. Model summary
TAU adheres to the ICMJE’s Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals (1), COPE’s Code of Conduct and Best Practice Guidelines for Journal Editors (2), and WAME’s policy (3) for generating this author instruction.
Source ↗Publisher website ·- License & copyright 6. COPYRIGHT AND PERMISSIONS
For specifications, please refer to: https://tau.amegroups.org/page/about/copyright-and-permission
Source ↗Publisher website ·- Open access Open Access Statement
This journal is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- AME Publishing Company
- Country or region
- China
- Language
- English
- ISSN
- 2223-4683
- Electronic ISSN
- 2223-4691
- Society / sponsor
- Society for Translational Medicine
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Translational Andrology and Urology
What CAS zone is Translational Andrology and Urology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Translational Andrology and Urology is in Zone 4 of Medicine, and in Zone 4 of the minor category Andrology / Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Translational Andrology and Urology?
The latest impact factor listed by LetPub is 1.88; CiteScore 2.4, h-index 64.
How long does peer review take at Translational Andrology and Urology?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 67 days (interquartile range 50–84 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Translational Andrology and Urology?
According to the journal's author guidelines: Abstract: 200–450 words; Keywords: 3–5; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Highlights: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Translational Andrology and Urology based?
Of the 55 board members whose country the journal's board page names, 4 (about 7%) are in mainland China; the countries named most often are United States (31), Mainland China (4) and Japan (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Translational Andrology and Urology?
According to LetPub and DOAJ records, Translational Andrology and Urology is indexed in SCIE and Scopus. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Translational Andrology and Urology open access, and what is the APC?
Translational Andrology and Urology is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .